Not everyone wants to inject medication. Good news: oral GLP-1 options exist and more are coming.
Approval Status at a Glance
| Pill | Approved for | FDA approval date | NDA |
|---|---|---|---|
| Rybelsus (oral semaglutide) | Type 2 diabetes | September 20, 2019 | 213051 |
| Wegovy pill (oral semaglutide 25 mg) | Weight management | December 22, 2025 | 218316 |
| Foundayo (orforglipron) | Weight management | April 1, 2026 | 220934 |
Status checked November 2026. The Wegovy pill also received EU approval on July 15, 2026. No other oral GLP-1 is FDA-approved for weight management as of this date — anything else marketed as a "GLP-1 pill" is either a supplement (not a drug) or a compounded product (not FDA-approved).
What Oral GLP-1 Options Exist?
Foundayo (Orforglipron) — Newest Option
The newest FDA-approved GLP-1 pill, approved April 1, 2026 (NDA 220934). Made by Eli Lilly.
- Daily pill with no food or water restrictions — take any time, with or without food
- Non-peptide GLP-1 receptor agonist (different from semaglutide)
- Dosing: starts at 3 mg, titrates up to 17.2 mg
- Weight loss: ~11% average over 72 weeks at the highest dose
- FDA-approved for weight management
This is the biggest advance in oral GLP-1 convenience. Foundayo removes the strict food-timing rules that made Rybelsus hard for many people. See our Foundayo guide for the full breakdown.
Rybelsus (Oral Semaglutide)
The first FDA-approved oral GLP-1, approved September 20, 2019 (NDA 213051). It's semaglutide in pill form, taken daily.
- Currently approved for type 2 diabetes
- Must take on empty stomach with no more than 4 oz of water
- Must wait 30 minutes before eating or drinking
- Dosing: 3 mg, 7 mg, 14 mg
Wegovy Pill (Oral Semaglutide for Weight Loss)
A once-daily oral semaglutide pill, FDA-approved for weight management on December 22, 2025 (NDA 218316) and available since January 2026. It also received EU approval on July 15, 2026.
- Same active drug as Rybelsus, but a more bioavailable formulation with its own dosing ladder
- Same food restrictions as Rybelsus
- Titrates from 1.5 mg up to the highest approved dose, 25 mg (a 50 mg dose was studied in trials but is not FDA-approved)
- In the OASIS 4 trial, patients on the 25 mg dose lost an average of 13.6% of body weight over 64 weeks, versus 2.2% on placebo
- Gives patients who hate needles a real alternative
How Oral GLP-1 Works
Like injections, oral GLP-1 pills:
- Mimic the GLP-1 hormone
- Reduce appetite
- Slow digestion
- Help control blood sugar
The catch with oral semaglutide (Rybelsus and Wegovy pill): they must be taken on an empty stomach with a small amount of water, and you need to wait before eating. Foundayo does not have this restriction.
GLP-1 medication news, in plain English
New approvals, pens, pills, prices and label changes across GLP-1 medications. One free email a week.
Pill vs Injection
| Feature | Foundayo (pill) | Rybelsus / Wegovy Pill | GLP-1 Injection |
|---|---|---|---|
| How often | Daily | Daily | Weekly |
| Needles | No | No | Yes |
| Food rules | None | Empty stomach, wait 30 min | None |
| Side effects | Similar GI symptoms | Similar GI symptoms | Similar GI symptoms |
| Weight loss | ~11% | Rybelsus: less data for weight; Wegovy Pill: ~13.6% average | Wegovy ~15%, Zepbound ~20% |
| Cost | Similar range | Similar range | Similar range |
Which Pill, for Whom?
- People afraid of needles
- People who prefer daily routines
- Anyone who has trouble with injections
- People who travel frequently and can't easily keep injections cold
| If you… | The pill that fits | Why |
|---|---|---|
| Want the simplest daily routine, no timing rules | Foundayo | No food or water restrictions — take any time, with or without food. See our Foundayo guide. |
| Want the most weight loss from a pill and can follow a morning routine | Wegovy pill | Strongest oral weight loss in clinical trials: 13.6% average in OASIS 4 (64 weeks), versus 2.2% on placebo. The tradeoff is strict timing — empty stomach, small sip of water, wait 30 minutes before eating or drinking. See our Wegovy pill vs injection comparison. |
| Have type 2 diabetes and prefer a pill | Rybelsus | The only oral GLP-1 approved for type 2 diabetes. Same food rules as the Wegovy pill. Not approved for weight management on its own. |
| Cannot follow a 30-minute empty-stomach routine | Foundayo, or an injection | The food rules are the reason many people stop Rybelsus. Foundayo removes them; weekly injections never had them. |
Foundayo specifically may be best if you:
- Could not handle the Rybelsus food restrictions
- Want the simplest daily pill routine possible
- Prefer no timing rules around meals
Products for daily pill users:
- Daily pill organizer - stay on track with daily dosing
- Water bottle with pill organizer - for proper pill administration
What to Ask Your Doctor
- Is an oral GLP-1 right for me?
- Which oral option is best — Foundayo or oral semaglutide?
- How does it compare to injections for weight loss?
- What side effects should I expect?
- What will it cost with my insurance?
- How do I take it for best results?
The Bottom Line
Oral GLP-1 pills give you the same benefits as injections without the needle. Foundayo goes further — no food rules, no water timing, just a daily pill. Talk to your doctor about whether a pill is right for you.
Talk to your doctor about the best treatment for you. This article is for information only and is not medical advice. Last updated: November 16, 2026.




